Product Information

EZETIMIBE-SIMVASTATIN 10-80 MG is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.4524 per EA under NDC 68462032430. Its NADAC has been published 326 times since Apr 1, 2020.

EZETIMIBE-SIMVASTATIN 10-80 MG

ezetimibe and simvastatin
$0.4524per EA

Strength

10; 80 mg/1; mg/1

NDC

68462032430

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

EZETIMIBE; SIMVASTATIN

Approval Type

Generic (ANDA)

FDA Application

ANDA208699

On Market Since

6/27/2019

Pharmacological Classes

Decreased Cholesterol Absorption
Dietary Cholesterol Absorption Inhibitor
HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for EZETIMIBE-SIMVASTATIN 10-80 MG has been published 326 times since Apr 1, 2020, and over the history we have for it it has declined 68.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4524 per EA
All-time high$2.0078 (Jul 15, 2020)
All-time low$0.3124 (Apr 17, 2024)
52-week high$0.4771
52-week low$0.3823
Median price$0.4964
Average price$0.7509
Largest weekly change-61.3% (Mar 23, 2022)
Weeks tracked326
Tracking sinceApr 1, 2020

Price History

1W

0.0%

1M

+1.1%

3M

-5.2%

6M

+16.5%

1Y

+18.4%

3Y

-11.8%

5Y

-45.6%

All

-68.4%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of EZETIMIBE-SIMVASTATIN 10-80 MG?

The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE-SIMVASTATIN 10-80 MG, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.4524 per EA (NDC 68462032430), effective Jun 24, 2026.

How has the price of EZETIMIBE-SIMVASTATIN 10-80 MG changed over time?

Over the history we have for it, the NADAC for EZETIMIBE-SIMVASTATIN 10-80 MG has declined 68.4%. It has been tracked across 326 weekly CMS publications since Apr 1, 2020.

What are the highest and lowest recorded NADAC prices for EZETIMIBE-SIMVASTATIN 10-80 MG?

Since Apr 1, 2020, the NADAC for EZETIMIBE-SIMVASTATIN 10-80 MG has ranged from a low of $0.3124 (Apr 17, 2024) to a high of $2.0078 (Jul 15, 2020), with a median of $0.4964 per EA.

Are there cheaper alternatives to EZETIMIBE-SIMVASTATIN 10-80 MG?

3 NADAC-published products share the same active ingredient, strength, and dosage form as EZETIMIBE-SIMVASTATIN 10-80 MG, but none are currently priced below it.

Who manufactures EZETIMIBE-SIMVASTATIN 10-80 MG?

EZETIMIBE-SIMVASTATIN 10-80 MG (NDC 68462032430) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.